NCT00183677View on ClinicalTrials.gov

Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram

PHASE4CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Depression
Interventions
DRUG

Escitalopram

Escitalopram 10 to 30 mg per day for 12 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00183677 - Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram | Biotech Hunter | Biotech Hunter